-
Mashup Score: 1An Iron Fist in a Velvet Glove: A Conversation with Dr. Atul Butte | NEJM AI Grand Rounds - 12 day(s) ago
In this episode, pioneering informatician Dr. Atul Butte guides listeners through his storied career, from his early days as a pediatric endocrinologist and informatician in Boston to his trailblazing work on the West Coast. Dr. Butte describes his trailblazing efforts to both harness large-scale public biomedical data and share patient data across the entire UC Health System. Dr. Butte also discusses his entrepreneurial journey, including the genesis and vision behind companies like NuMedii. Dr. Butte is the Priscilla Chan and Mark Zuckerberg Distinguished Professor at UCSF and the Chief Data Scientist of the UC Health System. Transcript
Source: ai-podcast.nejm.orgCategories: General Medicine NewsTweet
-
Mashup Score: 5
This cohort study evaluates the safety and clinical outcomes of immune checkpoint inhibitor therapy among patients with neurologic autoimmune disorders, including multiple sclerosis, myasthenia gravis, and Guillain-Barré syndrome.
Source: jamanetwork.comCategories: General Medicine NewsTweet-
“These findings suggest ICIs may be an option for many patients with appropriate oncologic indications and preexisting autoimmune neurologic disorders although they should be used with caution in patients with myasthenia gravis”@JAMANetworkOpen https://t.co/askhCmEHf8
-
-
Mashup Score: 95
Atkinson’s gleeful brilliance helped people draw on computer screens and access information via links.
Source: www.wired.comCategories: General Medicine NewsTweet-
RT @StevenLevy: RIP Bill Atkinson. One of a kind https://t.co/zu3wTPC8Vb
-
-
Mashup Score: 18ASCO/ESMO Joint Session at ASCO25 Will Highlight Key Issues in Biomarker-Driven Therapeutics - 27 day(s) ago
The ASCO/ESMO Joint Session at the ASCO Annual Meeting will explore emerging trends and clinical implications of integrating biomarker-driven therapies into clinical care. The session will address challenges and potential solutions in translating research into actionable treatments.
Source: dailynews.ascopubs.orgCategories: General Medicine NewsTweet-
ASCO/ESMO Joint Session at ASCO25 Will Highlight Key Issues in Biomarker-Driven Therapeutics https://t.co/amdtikxtka 🚀 @ASCO @myESMO @MassiveBio @mystlukes #ASCO25 @ASCOPres
-
-
Mashup Score: 17ASCO/ESMO Joint Session at ASCO25 Will Highlight Key Issues in Biomarker-Driven Therapeutics - 1 month(s) ago
The ASCO/ESMO Joint Session at the ASCO Annual Meeting will explore emerging trends and clinical implications of integrating biomarker-driven therapies into clinical care. The session will address challenges and potential solutions in translating research into actionable treatments.
Source: dailynews.ascopubs.orgCategories: General Medicine NewsTweet-
ASCO/ESMO Joint Session at ASCO25 Will Highlight Key Issues in Biomarker-Driven Therapeutics https://t.co/amdtikxtka 🚀 @ASCO @myESMO @MassiveBio @mystlukes #ASCO25 @ASCOPres
-
-
Mashup Score: 1The Most Clinically Relevant Science in Oncology Will Be Presented at ASCO25 - OncoDaily - 1 month(s) ago
The Most Clinically Relevant Science in Oncology Will Be Presented at ASCO25 / ASCO, ASCO25, cancer, OncoDaily, Oncology, Science in Oncology
Source: oncodaily.comCategories: General Medicine NewsTweet-
RT @oncodaily: The Most Clinically Relevant Science in Oncology Will Be Presented at ASCO25 @ASCO https://t.co/RKzydrtiFd #OncoDaily #On…
-
-
Mashup Score: 18ASCO/ESMO Joint Session at ASCO25 Will Highlight Key Issues in Biomarker-Driven Therapeutics - 1 month(s) ago
The ASCO/ESMO Joint Session at the ASCO Annual Meeting will explore emerging trends and clinical implications of integrating biomarker-driven therapies into clinical care. The session will address challenges and potential solutions in translating research into actionable treatments.
Source: dailynews.ascopubs.orgCategories: General Medicine NewsTweet-
ASCO/ESMO Joint Session at ASCO25 Will Highlight Key Issues in Biomarker-Driven Therapeutics https://t.co/amdtikxtka 🚀 @ASCO @myESMO @MassiveBio @mystlukes #ASCO25 @ASCOPres
-
-
Mashup Score: 9
Despite advanced algorithms, AI lacks certain human abilities. Arturo Loaiza-Bonilla MD, MSEd, explores Moravec’s paradox to highlight what the tech still can’t replace.
Source: www.medscape.comCategories: General Medicine NewsTweet-
My latest @Medscape 'Practical AI column' where we explore the question: Has “Dr Google” been reborn with a medical degree in Silicon Valley? Let’s dive in and find out!! #AI #AMIE @GoogleDeepMind | @demishassabis #moravec https://t.co/SIJfBQlfiX
-
-
Mashup Score: 72Scientists design gene delivery systems for cells in the brain and - 1 month(s) ago
NIH-funded breakthrough could enable targeted therapies for many neurological disorders.
Source: www.nih.govCategories: General Medicine NewsTweet-
RT @NIH: News: Scientists design gene delivery systems for cells in the brain and spinal cord https://t.co/zYNaGLkNgm
-
-
Mashup Score: 72Scientists design gene delivery systems for cells in the brain and - 1 month(s) ago
NIH-funded breakthrough could enable targeted therapies for many neurological disorders.
Source: www.nih.govCategories: General Medicine NewsTweet-
RT @NIH: News: Scientists design gene delivery systems for cells in the brain and spinal cord https://t.co/zYNaGLkNgm
-
For those wanting to learn more about him, his is a great @NEJM_AI episode: https://t.co/p65y4JtFOc @zakkohane